Background: Osteomyelitis is a well‐recognized manifestation of melioidosis, a significant disease that is endemic in South‐East Asia and northern Australia. Diagnosis requires a high degree of clinical suspicion and is dependent on microbiological confirmation; important clues are travel to or residence in an endemic area. Infection often but not always occurs in well‐recognized risk groups, especially diabetics and alcoholics. Subacute presentations often mimic other disease processes and patients may not always be clinically septic. Treatment requires surgical drainage in combination with multiple antibiotic therapy, including at least 2 weeks of intravenous ceftazidime and oral therapy continuing for 3–6 months. Non‐compliance usually results in relapse. Due to the potential long latency of the disease and the possibility of reactivation, follow‐up should probably be life‐long.
Methods: A prospective study of 115 patients presenting with melioidosis between 1989 and 1995 was undertaken.
Results: Four patients were found to have osteomyelitis.
Conclusion: It is important to be aware of this condition so that early treatment can be initiated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.